126 related articles for article (PubMed ID: 37470659)
1. Predictors of mortality among drug-resistant tuberculosis patients in Kaduna State, Nigeria.
Oyefabi AM; Tobin West CI; Ameh S; Jiya EN; Sadiq A; Dauda H; Onoh M
Niger J Clin Pract; 2023 Jun; 26(6):825-831. PubMed ID: 37470659
[TBL] [Abstract][Full Text] [Related]
2. Determinants of mortality among patients with drug-resistant tuberculosis in northern Nigeria.
Bajehson M; Musa BM; Gidado M; Nsa B; Sani U; Habibu AT; Aliyu I; Hussaini T; Yusuf A; Gida Y
PLoS One; 2019; 14(11):e0225165. PubMed ID: 31743358
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
4. Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study.
Baluku JB; Mukasa D; Bongomin F; Stadelmann A; Nuwagira E; Haller S; Ntabadde K; Turyahabwe S
BMC Infect Dis; 2021 Oct; 21(1):1093. PubMed ID: 34689736
[TBL] [Abstract][Full Text] [Related]
5. Survival of smear-positive multidrug resistant tuberculosis patients in Witbank, South Africa: A retrospective cohort study.
Olaleye AO; Beke AK
Infect Dis (Lond); 2016; 48(6):422-7. PubMed ID: 26954520
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcomes of Children With HIV Infection and Drug-resistant TB in Three Provinces in South Africa, 2005-2008.
Hall EW; Morris SB; Moore BK; Erasmus L; Odendaal R; Menzies H; van der Walt M; Smith SE
Pediatr Infect Dis J; 2017 Dec; 36(12):e322-e327. PubMed ID: 28746263
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection.
Alexander GR; Biccard B
Eur J Cardiothorac Surg; 2016 Mar; 49(3):823-8. PubMed ID: 26142471
[TBL] [Abstract][Full Text] [Related]
8. Predictors of mortality and loss to follow-up among drug resistant tuberculosis patients in Oromia Hospitals, Ethiopia: A retrospective follow-up study.
Woldeyohannes D; Tekalegn Y; Sahiledengle B; Assefa T; Aman R; Hailemariam Z; Mwanri L; Girma A
PLoS One; 2021; 16(5):e0250804. PubMed ID: 33956812
[TBL] [Abstract][Full Text] [Related]
9. Intensive-phase treatment outcomes among hospitalized multidrug-resistant tuberculosis patients: results from a nationwide cohort in Nigeria.
Oladimeji O; Isaakidis P; Obasanya OJ; Eltayeb O; Khogali M; Van den Bergh R; Kumar AM; Hinderaker SG; Abdurrahman ST; Lawson L; Cuevas LE
PLoS One; 2014; 9(4):e94393. PubMed ID: 24722139
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
Ejeh FE; Undiandeye A; Okon K; Moshood KH
Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
[TBL] [Abstract][Full Text] [Related]
11. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
[TBL] [Abstract][Full Text] [Related]
12. High mortality among patients hospitalized for drug-resistant tuberculosis with acquired second-line drug resistance and high HIV prevalence.
Anderson K; Pietersen E; Shepherd BE; Bian A; Dheda K; Warren R; Sterling TR; van der Heijden YF
HIV Med; 2022 Nov; 23(10):1085-1097. PubMed ID: 35608016
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function in multidrug-resistant tuberculosis patients with or without human immunodeficiency virus (HIV) infection before commencement of MDR-TB drug regimen.
Ige OM; Akinlade KS; Rahamon SK; Edem VF; Arinola OG
Afr Health Sci; 2016 Jun; 16(2):596-602. PubMed ID: 27605977
[TBL] [Abstract][Full Text] [Related]
14. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-EchevarrÃa A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
[TBL] [Abstract][Full Text] [Related]
16. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.
Zhang L; Xing W; Zhou J; Zhang R; Cheng Y; Li J; Wang G; Liu S; Li Y
BMC Infect Dis; 2020 Aug; 20(1):576. PubMed ID: 32758169
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria.
E Ahiarakwem II; Ekejindu IM; Akujobi CN; Aghanya IN
Niger J Clin Pract; 2020 Aug; 23(8):1172-1177. PubMed ID: 32788498
[TBL] [Abstract][Full Text] [Related]
20. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
